Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum

OBJECTIVES: Our objective was to evaluate the pharmacokinetics of nelfinavir (NFV) (625 mg tablets) 1250 mg twice daily during pregnancy and postpartum. METHODS: The participants were HIV-1-infected pregnant women enrolled in P1026s and receiving NFV (625 mg tablets) 1250 mg twice daily as part of r...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Read, JS, Best, BM, Stek, AM, Hu, C, Capparelli, EV, Holland, DT, Burchett, SK, Smith, ME, Sheeran, EC, Shearer, WT, Febo, I, Mirochnick, M
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2008
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2732353/
https://ncbi.nlm.nih.gov/pubmed/18795962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1468-1293.2008.00640.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk